An experimental cancer “vaccine” showed promising results in a small clinical trial of patients with lymphoma, according to a study published Monday in the journal Nature Medicine.
Researchers at New York’s Mount Sinai Hospital tested the treatment in 11 patients with lymphoma. Their results were successful enough to warrant another clinical trial in March on lymphoma patients as well as breast and head-and-neck cancer.
CHUYỆN GÌ THẾ? Ở ĐÂU? VÀ TẠI SAO LÀ LÚC NÀY?
Bốn người bạn trúng giải Lotto Max kỷ lục 90 triệu đô
Một em bé 4 tuổi ăn phải chocolate Halloween chứa cần sa
Ngân sách liên bang vừa công bố ảnh hưởng thế nào đến đời sống của bạn?
Researchers said some patients in the initial human trial went into full remission for months or even years.
The treatment “has broad implications for multiple types of cancer,” said lead author, Dr. Joshua Brody, director of the lymphoma immunotherapy program. “This method could also increase the success of other immunotherapies such as checkpoint blockade.”